Palbace (palbociclib) capsules. FDA-Approved

Palbace (palbociclib) capsules can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of Palbace (palbociclib) capsules to Breast cancer.
Category: .

Palbace (palbociclib) capsules. FDA-Approved

What is FDA-approved Palbace (palbociclib) capsules indicated for?

Palbace (palbociclib) capsules is a prescription medicine. Palbace (palbociclib) capsules is used to treat Ovarian cancer and Breast cancer.
INDICATIONS AND USAGE
Palbociclib is a kinase inhibitor indicated in a combination with Letrozole for the treatment of postmenopausal women with estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease. Palbociclib is a kinase inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)- negative advanced or metastatic breast cancer in the combination with fulvestrant in women with disease progression following endocrine therapy.
DOSAGE FORMS & STRENGTHS
Each capsule contains 125 mg, 100 mg or 75 mg of Palbociclib.
Manufactured By: Pfizer Products India Private Limited
Prescribing Information URL: Click Here

How to make an enquiry for Palbace (palbociclib) capsules?

Anticancer medicine Palbace (palbociclib) capsules available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Breast Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer.

What Palbociclib is indicated for?

Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.

The drug was reviewed and approved under the Food and Drug Administration’s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor positive (ER+) advanced breast cancer. This was an accelerated approval.

In March 2017, the FDA granted regular approval to palbociclib for hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor.

In December 2017, palbociclib, was accepted for use by the NHS after going through the Scottish Medicines Consortium's process for medicines used to treat very rare and end-of-life breast cancer.

How and where to buy Palbace (palbociclib) capsules?

You can order Palbace (palbociclib) capsules from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer. To get best price/cost of Palbace (palbociclib) capsules in India, Call 8750295029 or Email urgent@medvitaz.com

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.